Xenex manufactures and develops UV light disinfection robots, which assist hospitals to minimize their Hospital Acquired Infections (HAIs)
Xenex’s pulsed Xenon UV light approach destroys more pathogens and in less time than their competitors, while integrating into hospital cleaning operations in an easy-to-operate manner. Equally as important as its technology, Xenex has built a high-touch commercial organization and the company’s focus on customer support has translated into strong retention and integration within its hospitals.The benefits to the hospitals in which these robots are utilized include improved profitability through higher reimbursement, enhanced patient health and satisfaction, decreased cost of care, and a payback period of four to nine months from the initial procurement. Xenex currently has 1,500+ robots in service among clients who include the Mayo Clinic, MD Anderson Center, and Stanford University Hospital and Clinics, among other well-known healthcare facilities.
“We are thrilled to partner with EW. With their understanding of the medical device space and how companies should operate, EW has added value from ‘Day 1’. We were very impressed with the careful diligence conducted by the EW team, and we look forward to a great future together!”
CEO, Xenex
Testimonials and endorsements reflect portfolio company management’s opinions and beliefs regarding the company and the investment. Such opinions and beliefs are subjective, do not represent a complete assessment of the company, the market or EW’s overall investment performance and cannot be independently verified. Such statements are being offered as references for purposes of demonstrating the benefits of working with the EW team and not for the purpose of soliciting investors. Portfolio company executives receive/received a salary and economics from the portfolio company. No executives were paid for their testimonial or endorsement. There is a conflict of interest in these unpaid testimonials and endorsements in that all speakers stand to benefit from EW’s success and they work/worked for an EW portfolio company.
All content © 2024
Legal Disclaimer | Privacy Notice
Powered by 